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1. Introduction 
Obstetrics is one of the major areas in medicine requiring blood transfusion. In the UK about 
4000 cases of severe obstetric haemorrhage take place each year, of which most of the patients 
need blood transfusion (RCOG Green top guideline no. 47). On one hand maternal morbidity 
and even mortality depends on availability of blood and blood products and on the other hand 
injudicious use of blood and blood products can cause infection, allergic reaction or antibody 
production in the mother which can have major impact on the present or future pregnancies 
(Blood transfusion in obstetrics , RCOG Green top guideline no. 47). The most common 
complication of blood transfusion is error in transfusion. In the UK, SHOT (Serious Hazard Of 
Transfusion) is informed about all the complications of transfusion.  The largest category of 
untoward incidents reported to SHOT is ‘incorrect blood component transfused’ (71%) and the 
incidence is on the rise (SHOT in Obstetrics: 2005 Annual Report). In this chapter we will 
discuss the main indication for blood transfusion in obstetric practice in developed world and 
the ways to prevent blood transfusion. 
In modern day obstetric practice, the complications of blood transfusion is well-recognised 
and in many hospitals in the UK, protocols are in place to boost pre-delivery haemoglobin, 
so that blood transfusion can be avoided in case of postpartum haemorrhage. If the mother 
has low haemoglobin in the antenatal period then oral iron supplement (Ferrous Sulphate or 
Ferrous Fumerate) should be given. Intravenous iron is indicated when there is poor 
tolerance to oral iron or a quick response is needed. There are two main preparations: iron-
dextran and iron sucrose. There is evidence that intravenous iron therapy replenishes iron 
stores faster and more efficiently than oral iron therapy (Singh et al 1998). Recombinant 
human erythropoietin is used when anaemia is caused by renal disease. It is safe to use in 
pregnancy and there is no reported cases of teratogenicity (Braga et al 1996). 
There are two main indications for blood transfusion in obstetrics: Ante Partum Hemorrhage 
(APH) and Post Partum Hemorrhage (PPH). The other important and common indication for 
blood transfusion in pregnancy is ectopic pregnancy, which like miscarriage may be 
considered as a gynaecological cause in most units. In the developing world obstetric 
haemorrhage is the most important cause for maternal morbidity and sometimes mortality 
(Saving Mothers’ Lives: CEMACH Report 2003-2005). In view of all the complications of the 
blood transfusion, it is only prudent to use blood and blood products with caution and when 
appropriate. All the other pharmacological agents should be used first. The newer techniques 
of management of PPH (Intrauterine balloon, use of cell salvage and recombinant factor seven) 
have revolutionised management of PPH in developed world.   
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Anaemia in pregnancy: It is hard to determine the prevalence of anaemia in pregnancy in 
both developing and developed world due to the difference in definition of anaemia 
worldwide. In the developing world it is found in most severe form whereas in the 
developed world it is mild. In a comprehensive report on prevalence of anaemia worldwide 
by WHO (WHO Global Database on Anaemia), the prevalence of anaemia in Afghanistan 
was highest (61%). In the developed world prevalence of severe anaemia is uncommon 
(USA 5.7 % of pregnant women and UK 15.2%) .However, in the developed world it is 
seldom an indication for blood transfusion by itself, when there is no ongoing bleeding or 
haematological disorder has not been incriminated as the cause for the anaemia.  
2. Early pregnancy complications 
There are two main types of early pregnancy complications may need blood transfusion - 
Miscarriage and ectopic pregnancy.  
There are different types of miscarriages: 
a. Threatened miscarriage 
b. Incomplete miscarriage 
c. Complete miscarriage 
d. Inevitable miscarriage 
e. Missed miscarriage 
Patients classically presents with heavy vaginal bleeding and cramp like lower abdominal 
pain in most of the types. Missed Miscarriage may remain asymptomatic and sometimes an 
incidental finding during routine ultrasound examination. Speculum examination may 
reveal open cervical os in case of incomplete and inevitable miscarriage. Bleeding can be 
heavy and sometimes clinically underestimated. Careful assessment of bleeding and timely 
decision of operative management can prevent unnecessary blood transfusion and 
prolonged hospital stay. 
2.1 Ectopic pregnancy 
Ectopic pregnancy is defined as implantation of blastocyst at a site other than uterine cavity. 
It may develop in the fallopian tube (most common), ovaries or even peritoneum.  
The main complication of ectopic pregnancy is rupture and if prompt medical attention is 
not given, it can even be fatal due to intraperitoneal bleeding from the ruptured fallopian 
tube. It is a common and important cause of maternal morbidity and mortality worldwide, 
especially in developing countries, where prompt medical care and facilities for blood 
transfusion is not available. Even in developed countries like UK, the morbidity and 
mortality can be high. There were 13 maternal deaths deaths from ruptured ectopic 
pregnancy in 1997-1999 (CEMACH report 2001) 
2.1.1 Risk factors for ectopic pregnancy 
Idiopathic 
Salpingitis - Possibility of sexually transmitted infection should be excluded (Ankum et al 1996) 
Previous ectopic pregnancy (Bouyer et al 1996) 
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Failure of sterilisation 
History of infertility 
Increased Maternal age 
2.1.2 Presentation 
The patient typically presents with pain in one of the iliac fosse which may or may not be 
associated with vaginal bleeding. The pain and bleeding can be of varying severity. 
Sometimes the patient may pass decidual cast with vaginal bleeding which can be confused 
with product of conception. 
2.1.3 Diagnosis 
Ectopic pregnancy is difficult to diagnose clinically as most of the time the patient 
compensates for bleeding and not tachycardic or hypotensive unless significant 
intraperitoneal bleeding has taken place. Speculum examination of the cervix may be 
helpful in excluding miscarriage where the cervical os is open. Vaginal examination may 
show cervical excitation which, if positive, points towards ectopic pregnancy. However it is 
not a specific test for ectopic. Ultrasound scan is the investigation of choice. Also, in 
asymptomatic patients, serial BHCG can be checked to exclude ectopic pregnancy. 
2.1.4 Management 
There are two main treatment options- Surgical and Medical. An expectant approach may be 
taken in some selective asymptomatic patients with variable success. 
Surgical: Laparoscopic salpingectomy is the surgical method of choice in hemodynamically 
stable patients. Compared to laparotomy, it is associated with less intraoperative blood loss, 
shorter operative time and shorter hospital stay (Murphy et al 1992 and Gray et al 1995) 
If the patient is not hemodynamically stable, management should be by quickest method, 
which in most cases is by laparotomy. However, it does depend on surgeon’s expertise 
(RCOG Guideline no 21). Crossmatched blood should be available prior to operation as it is 
difficult to predict the degree of haemorrhage. 
If the contralateral tube is not healthy, a salpingotomy can be considered instead of 
salpingectomy to increase the chance of intrauterine pregnancy in future (Silva et al 1993) 
Medical Management: Methotrexate is used for the management of ectopic pregnancy in a 
stable patient. The patient should always be counselled about the possibility of rupture. 
Lipscomb et al. (1998) has shown methotraxate to be as effective as surgery in suitable patients.  
All mothers with Rh negative blood group should receive Anti D immunoglobulin (RCOG 
Guideline no 21).  
3. Antepartum Haemorrhage  
Antepartum Hemorrhage (APH) classically is described as any bleeding from the genital 
tract after 24 weeks of pregnancy. Spotting or minimal bleeding is common in pregnancy 
and cervical cause, such as ectropion should be ruled out first. If the patient is having 
regular contraction, heavy show (which is a sign of labour) should be ruled out as well. 
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There are two major causes of APH -Placenta previa & Placental Abruption which might 
need blood transfusion. 
3.1 Risk assessment for APH 
(RCOG. Green top Guideline No. 27 & National Collaborating Centre for Women’s and 
Children’s Health. Antenatal care: Clinical Guideline. 2003). 
 During the anomaly/detailed ultrasound scan at 18-22 weeks:placental localisation 
should be done. 
 Further scans after 30 weeks to confirm low-lying placenta,if placenta was found to be 
low in the earlier scans. 
 Anaemia, if present to be corrected during antenatal period 
 If previous caesarean section: exclude placenta accreta exclude placenta accreta in the 
third trimester 
 In case of placental abruption: Remember that there might be concealed bleeding and 
not all of the bleeding is apparent. 
3.2 Diagnosis of placenta previa 
Placenta previa is defined as when the placenta covers the internal os of the cervix partly or 
fully in such a way as to prevent the baby’s head to deliver vaginally. It is one of the most 
important causes for maternal morbidity in obstetrics and contributes not only to 
Antepartum haemorrhage, but also post partum haemorrhage (Onwere et al 2011). It is 
divided into two categories by ultrasound scan: Major, when the placenta covers the internal 
os fully and minor, when it is close to internal os but does not cover it fully.  Transvaginal 
ultrasound scan is vital in diagnosing placenta previa, especially when it is posterior 
(RCOG. Green top Guideline No. 27 & Leerentveld RA 1990).   
 
Clinical  Signs/symptoms
1. Recurrent painless vaginal bleeding in third trimester 
2. Persistent malpresentation such as transverse lie, breech, oblique lie. 
3. High presenting part in labour
Ultrasound Scan: 
1. Suspect at anomaly scan (second trimester) 
2. If placenta is low-lying in second trimester scan, confirm placental position in third 
trimester 
3. Ultrasound scan if sufficient degree of suspicion ,even when the placenta is not noted 
to be low-lying in second trimester  
4. Transvaginal ultrasound is safe and particularly useful in posterior placenta previa 
5. Possible to diagnose placenta accreta or percreta by ultrasound scan.  
MRI Scan: Reserved for suspected placenta accreta, percreta and increta
Table 1. Diagnosis of Placenta Previa. 
3.3 Placental abruption 
Abruption on the other hand is the separation of the placenta from the uterine wall. The 
bleeding resulting from the separation can be fully or partly revealed or sometimes can be 
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concealed. The problem of concealed bleeding is that a major internal haemorrhage can take 
place before the patient becomes symptomatic. Hence, it can be difficult to diagnose and 
manage. The patient typically presents in third trimester with severe abdominal pain and 
vaginal bleeding with or without intra-uterine fetal death. The uterus has classically been 
described as woody hard. Sheiner et al showed that the perinatal morbidity and mortality is 
significantly higher in placental abruption (OR = 30.0, 95% CI 19.7-45.6; p < 0.001). Common 
causes of placental abruption are mentioned in table 2. 
3.3.1 Diagnosis of placental abruption 
Diagnosis of placental abruption is mainly clinical. The patient commonly presents with 
abdominal pain and vaginal bleeding. Bleeding is generally less severe than placenta 
previa. It is important to rule out concealed bleeding. In case of significant abruption the 
CTG may show fetal distress or even intrauterine fetal death. The condition is sometimes 
complicated by disseminated intravascular coagulopathy. Management is by delivery of 
the baby if there is evidence of fetal distress. If there is intrauterine death, vaginal delivery 
can be considered after correction of coagulopathy. Management plan should be 
discussed with the anaesthetist, haematologist and paediatrician- if there is fetal distress 
or preterm delivery. 
 
 Pregnancy induced hypertension: pre-eclampsia and eclampsia (Ananth et al 1997) 
 Polyhydramnios or oligohydramnios (Hung  et al 2007) 
 Cocaine misuse (Mbah et al 2011) 
 Trauma (OR = 10.0; 95% CI 3.9-25.5; P < 0.001) (Weintraub 2006) 
 Maternal diabetes (Dafallah & Babikir 2004) 
Table 2. Common causes of abruption of placenta 
3.4 Management of major antepartum haemorrhage 
3.4.1 Management of placenta previa  
Management of placenta previa depends on different factors. The first and foremost is the 
bleeding. If the mother is symptomatic, i.e. presents with severe vaginal bleeding, delivery is 
indicated. At this stage fetal maturity is irrelevant and delivery should be considered in the 
maternal interest. If the mother is in labour with known major degree placenta previa a 
prompt caesarean section is indicated. In this situation, senior help should be sought 
urgently and blood should be crossmatched. The mother should be counselled about 
possibility of caesarean hysterectomy beforehand. If the mother is asymptomatic and the 
fetus is still premature, conservative management is reasonable with or without hospital 
admission. If the mother is asymptomatic and fetus is matured, delivery by elective 
(planned) caesarean section is indicated. 
Vaginal bleeding in case of placenta previa is sudden and can be moderate to severe. 
Usually it is preceded by repeated ‘warning’ bleeds. The CTG of the fetus usually does not 
show any abnormality. 
Elective caesarean section is the method of choice for the delivery of the fetus, but many 
patients need emergency caesarean section for moderate to severe unexpected bleeding. In 
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case of major placenta previa, when an anterior placenta covers the whole lower segment, 
caesarean section can be technically difficult and complicated by severe haemorrhage; hence it 
should be performed electively by a senior obstetrician with senior anaesthetist caring for the 
woman and senior paediatrician caring for the baby. The risk of massive haemorrhage and 
possibility of hysterectomy should be discussed with the patient prior to the operation if time 
permits and should be documented in the consent as both the risks are considerably higher 
(about 12 times more chance of blood transfusion and about one third might need 
hysterectomy)..Delivery should be considered in asymptomatic placenta previa around 38 
weeks of gestation. Some units offer in patient management from third trimester in cases of 
major placenta previa. In these cases two units of cross matched blood should be kept in fridge 
which should be replaced by newly crossmatched blood every week (British Committee for 
Standards in Haematology. Blood Transfusion Task Force 2004). The decision for delivery 
should be made by the consultant obstetrician and proper evaluation of each case is required. 
Management of symptomatic Placenta previa (The MOET course Manual): Communication 
is the key to proper management. It is easy to underestimate bleeding, hence weighing of 
the sheets will be more accurate indicator of the amount of blood loss. The management of 
acute bleeding has been outlined in table 3. 
 
 Manage Airway, Breathing, Circulation 
 Assessment of the bleeding 
 Intravenous access: 2 large bore (16 gauge) cannulae 
 Blood for Full Blood count, coagulation profile, Crossmatch   
 Indwelling catheter to monitor urine output 
 Fluid resuscitation 
 Crossmatch bloods and availability of blood products: alert Blood Transfusion that 
more blood may be needed 
 Alert: Senior-most Obstetrician, Anaesthetist, Paediatrician, Hematologist, Blood 
Transfusion Service 
 If life threatening bleeding – consider group specific or O negative blood 
 Decision for delivery/conservative management: Senior Obstetrician should be 
involved. 
Table 3. Management of symptomatic Antepartum haemorrhage 
3.4.2 Management of major placental abruption 
In case of suspected significant abruption, delivery is indicated in both maternal and fetal 
interest. In severe placental abruption, delivery by caesarean section is indicated. If the 
mother presents with signs of abruption with a viable fetus which is distressed, prompt 
delivery improves outcome (Kayani et al 2003). If the mother is symptomatic and the fetus 
is already dead, artificial rupture of membrane can be performed and a trial for a vaginal 
delivery can be undertaken. However, if the bleeding is severe, then caesarean section 
might be the appropriate mode of delivery in maternal interest irrespective of the status of 
the fetus.  
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4. Postpartum Haemorrhage (PPH) 
4.1 Introduction 
It is one of the most common causes for maternal mortality and morbidity worldwide. In 
Scotland, the rate of life-threatening haemorrhage is about 3.7/1000 (Brace, Kernaghan & 
Penney 2007). Life threatening haemorrhage includes bleeding more than 2.5 litres or the 
patients who need treatment to correct coagulopathy or where more than five units of blood 
have been transfused. 
The WHO has defined postpartum haemorrhage as any bleeding from the genital tract over 
500mls.after the delivery of the baby. In the developed world, most mothers show no sign of 
hypovolumia till 1000 mls of blood is lost (Drife 1997). Hemorrhage within 24 hours of 
delivery is termed as primary and a haemorrhage after 24 hour is termed as secondary. 
Common causes of PPH are uterine atony, vaginal or cervical trauma, retained placental 
tissue or membranes and Disseminated Intravascular Coagulopathy (DIC), out of which the 
commonest being uterine atony (70%), where the uterus fails to contract after delivery. This 
is a situation where urgent action is life-saving and may require transfusion of multiple 
units of blood and blood products. The clotting factors are exhausted quickly and unless 
they are replenished as part of resuscitation, there is little chance that bleeding will be 
controlled by simply blood transfusion. However, prompt action and transfusion of blood 
and blood products can save life and even preserve uterus in cases of massive haemorrhage. 
4.2 Strategies to prevent major Post Partum Haemorrhage 
It is possible to prevent major obstetric haemorrhage and subsequent blood transfusion in 
majority of the anticipated cases.All the factors mentioned in table 4 have been identified as 
risk factors for PPH and if the patient is at higher risk ,it should be clearly documented in 
the notes and communicated to the relevant health professionals. In four cochrane reviews 
active management of third stage of labour has been found superior to physiological third 
stage (Prendiville 2000). Active management of third stage include early cord clamping, 
controlled cord traction and early uterotonic drugs such as syntocinon,ergometrine or 
syntometrine as per local protocol. Proper risk assessment in the antenatal period and 
individualisation of cases are the vital steps which must be taken in order to prevent blood 
transfusion. 
 
 Parity: Primiparity or Grand Multiparity 
 Prior Caesarean section  
(Kramer et al 2011 ) 
 Placenta previa or low-lying placenta, 
marginal umbilical cord insertion in the 
placenta 
 Past history of PPH 
 Placenta previa or accreta in previous 
pregnancy 
 Labour induction and augmentation 
( Kramer et al 2011) 
 Prolonged labour 
 Uterine or cervical trauma at 
delivery 
 Transverse lie 
 Gestational age < 32 weeks 
 Birth weight ≥ 4500 g. 
 Multiple pregnancy 
Table 4. Risk factors for PPH  
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4.3 Management of major Post Partum Haemorrhage 
Most of the time PPH is unpredictable and pose major health concern when they are severe. 
If PPH is anticipated proper steps should be taken to reduce the likelihood of blood 
transfusion and maternal morbidity. These steps include use of cell salvage if available, 
support from senior obstetrician, senior anaesthetist and other health professionals. 
Uterus should be rubbed up for a contraction should be the first step and sometimes this is 
enough to reduce blood loss. Pharmacological agents such as oxytocin, ergometrine and 
prostaglandins (intramuscular or Intramyometrial) injections remain the mainstay of 
management. Effective communication between the health professionals is important as 
resuscitation should run side by side to the definitive management. 
If bleeding is uncontrollable with pharmacological agents, surgical measures such as Brace 
sutures, Examination under anaesthesia (EUA) and repair of cervical or uterine injury are 
undertaken. Intrauterine Balloon is one of the most common and effective method of 
controlling moderate to severe PPH. 
If facilities permit, Interventional radiologist and haematologist should be involved early as 
often the PPH can lead to DIC and will be requiring expert input. The interventional 
radiologist will play a key role if the bleeding is from any branch of internal or external iliac 
artery. If this facility is not available either hysterectomy or transfer of the patient to a 
tertiary referral centre after stabilisation should be considered. 
 
 Assessment of Bleeding 
 Indwelling Catheter 
 Rubbing up a contraction 
 Ask for help 
 Multidisciplinary approach, including Senior obstetrician, senior anaesthetist, Senior 
midwives, 
 Airway, Breathing and circulation 
 2 large bore cannulae 
 Frequent monitoring of BP, Pulse, oxygen saturation, urine output and vaginal 
bleeding 
Medical Management: 
 Oxytocin bolus  
 Oxytocin infusion 
 Ergometrine 
 Prostaglandin: Intramuscular, Intramyometrial, Per-rectal 
Surgical Management: 
 Brace sutures 
 Intrauterine Balloon 
 Internal Iliac artery ligation 
 Hysterectomy 
Interventional Radiology 
Recombinant factor VII concentrate: Not licensed for use in the UK for treatment of PPH 
Table 5. Summary of Management of PPH 
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Recombinant Factor VII concentrate (rFVIIa): Not licensed for use for obstetric haemorrhage, 
but can be used when benefit outweighs risk. Senior haematologist should always be 
involved in the decision making. Franchini, Lippi & Franchi, in a review of published data 
of 65 women treated with rFVIIa for PPH, suggested that rFVIIa reduced bleeding. 
Hysterectomy should be considered as a last resort. A timely hysterectomy can save life. 
5. Blood transfusion in APH & PPH 
Ideally, fully cross matched blood is preferable in case of major obstetric haemorrhage. 
However, obstetric haemorrhage is extremely unpredictable and it is not always possible to 
wait for fully cross matched blood. Generally volume replacement should start with up to 2 
litres of crystalloid. Plasma expanders should follow until the blood is available (The MOET 
course Manual). If the haemorrhage is life-threatening, O negative or type specific blood 
should be used. In most hospitals O negative blood is readily available either in the labour 
suite or at the on-site blood bank. Patients, who are at higher risk of haemorrhage, should be 
admitted and delivered in a unit where blood and blood products are readily available 
(CEMACH Sixth Report, 2004).  
6. Risk management  
Availability of blood does not always guarantee best standard of care to the patients. 
Standard of care depends on the team-work and competence of the healthcare professionals. 
Two strategies can be employed to improve these factors. The doctors and other healthcare 
professionals should attend appropriate course to maintain their skills and update their 
knowledge of both resuscitation and managing obstetric emergencies to improve health 
professionals’ knowledge. The other important step is to organise regular obstetric 
emergency drills (commonly known as obstetric fire drills in the UK). 
A local protocol should be in place to manage major obstetric haemorrhage and regular 
audit of practice and analysis of cases with major blood loss should be carried out. This is 
vital as lessons are to be learned from every mistake made to improve patient care in future. 
Also, emphasis should be given to the importance of appropriate and detailed 
documentation including the timings of steps of medical and surgical management.  
7. Morbidly adherent placenta 
The Royal College of Obstetricians and Gynaecologists (UK) have brought out an excellent 
guideline (Green top Guideline No. 27) on the management of morbidly adherent placenta 
(placenta accreta, increta and percreta). From the guideline and searching other literature, 
the salient points are: 
 The incidence of placenta previa accreta is on the rise as the incidence of caesarean 
section is rising 
 The patient should be reviewed by the consultant obstetrician and consultant 
anaesthetist in the antenatal period and a proper plan should be documented. 
 The consent form should include discussion about Interventional Radiology, Cell 
salvage, Recombinant Factor VII concentrate and hysterectomy.  
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 Interventional Radiology can be safely and effectively used for an elective caesarean 
section (Jung et al 2011). Intra-arterial balloon can be inserted before the procedure.  
 At caesarean section the uterus should be opened distal to the placenta so that the baby 
can be delivered undisturbed and to have the option of conservative management. 
 If the placenta is covering the whole anterior lower segment, a midline skin incision will 
not be unreasonable. 
 If the placenta fails to separate at caesarean section and bleeding is minimal, it can be 
left in situ. Attempting placental separation risks hysterectomy in up to 100% of cases  
(Eller et al 2009).If there is major haemorrhage, the uterine wound should be closed and 
a subtotal or total hysterectomy can be performed 
  If the placenta is left behind serial ultrasound scan and beta HCG monitoring should be 
performed. Post operative antibiotics should be given to minimise the risk of infection 
and close monitoring is needed to diagnose infection early. 
8. Interventional radiology in anticipated intrapartum and postpartum 
haemorrhage 
In case of major placenta previa or known morbidly adherent placenta, interventional 
radiology can be used to minimise the risk of potential PPH. The Radiologist may insert the 
balloons preoperatively either in the uterine artery or in the anterior division of internal iliac 
artery which can be inflated preoperatively to minimise in case of uncontrollable 
haemorrhage or even can be used for embolisation. The overall success rate of interventional 
radiology in controlling bleeding and avoidance in hysterectomy rate has been quoted 
around 71-97% (Dildy GA 3rd 2002 &. Hong et al 2004)  
In a large study (involving sixty six women, who have undergone embolisation) in Boston, 
USA, Ganguly et al suggested that the ‘threshold for Uterine Artery Embolisation in women 
with PPH should be low, as it is associated with a high clinical effectiveness rate and a low 
complication rate’.  
9. Cell salvage 
Cell salvage is an effective way of reducing blood transfusion rate in women where the 
anticipated blood loss is more than 1.5 litres (RCOG Green top guideline no. 47). Prior 
consent is necessary for this procedure. In intra-operative cell salvage blood is collected 
usually after the liquor is drained then collected in a reservoir centrifuged, washed and 
processed for transfusion. In a case series in a large maternity unit in the UK, introduction of 
cell saver has been a major factor in reducing heterologous blood transfusion from 10.2% to 
7.9% (King et al 2009). The main problem with this process is that there is no available filter 
to filter out fetal cells. Hence, a Kleihauer test is necessary after its use.  
10. Management of patients refusing blood transfusion on religious/ethical 
belief 
Some women, mostly due to their religious belief, decline blood or blood products 
transfusion. Most common of these groups are Jehovah’s witnesses and transfusing them 
under any circumstances without their consent may be considered as to assault, hence 
www.intechopen.com
 
Scope of Blood Transfusion in Obstetrics 93 
should not be undertaken even if it is indicated. In UK, legally a woman can decline 
treatment even if it might prove fatal. But this is a decision, only a competent patient can 
make and no one else. Also, if she has declined transfusion, no one else can make a decision 
on her behalf to transfuse her.  
A detailed discussion regarding the risks should take place at first or second trimester. The 
discussion should also include possibility of hysterectomy, morbidity and possibility of 
death. Two large case series in UK (Massiah et al 2007) and USA (Singla et al 2001) looked 
into the obstetric outcome of the labour and deliveries in Jehovah’s witnesses. The reported 
mortality rate is 65 fold higher in the UK and 44 fold higher in USA. 
A written consent should be taken during the antenatal period after a detailed discussion 
about pros and cons of the decision.  Anaemia should be corrected aggressively before 
delivery, if necessary with intravenous iron therapy. Prior consent about cell salvage should 
be taken if the patient is due to have elective caesarean section or even in emergency 
caesarean section if time and facilities permit. This cell salvage should run in continuous 
loop without disconnection till the end of the procedure (Currie et al 2010).  In these patients 
prompt decision making about prevention of PPH and using all the relevant uterotonics and 
surgical methods (intrauterine compression balloon, brace sutures, interventional radiology) 
are vital and if necessary hysterectomy should be undertaken sooner rather than later. The 
patient’s wishes should be respected and it is not legally and ethically justified to transfuse 
her against her wishes. Senior input from the obstetric and anaesthetic consultants should be 
sought early. 
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